Two Sigma Advisers’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-101,700	Closed	-$4.16M	–	2590
2024 Q2	$4.16M	Buy	101,700 +58,900	+138%	+$2.41M	0.01%	845
2024 Q1	$1.81M	Buy	+42,800	New	+$1.81M	﹤0.01%	1283